BCX4430, a Novel Nucleoside Analog, Effectively Treats Yellow Fever in a Hamster Model

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

(2014) Travis K. Warren et al.   NATURE

Experimental therapies for yellow fever

(2012) Justin G. Julander   ANTIVIRAL RESEARCH

Review of the risks and benefits of yellow fever vaccination including some new analyses

(2012) Thomas P Monath   Expert Review of Vaccines

Treatment of Yellow Fever Virus with an Adenovirus-Vectored Interferon, DEF201, in a Hamster Model

(2011) Justin G. Julander et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model

(2011) Justin G. Julander et al.   VACCINE

Efficacy of 2′-C-methylcytidine against yellow fever virus in cell culture and in a hamster model

(2010) Justin G. Julander et al.   ANTIVIRAL RESEARCH

The dengue vector Aedes aegypti: what comes next

(2010) Cassie C. Jansen et al.   MICROBES AND INFECTION

Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity

(2010) Thomas P. Monath et al.   VACCINE

Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106

(2008) J. G. Julander et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment of yellow fever

(2007) Thomas P. Monath   ANTIVIRAL RESEARCH